Sanket Koul

Lilly claims its oral GLP-1 outperformed oral semaglutide in diabetes trial

Drugmaker plans to submit orforglipron to USFDA for Type 2 diabetes approval by end of second quarter

Vertex Group to invest ₹300 crore in smart co-working centres over 3 years

Group launches full-stack smart co-working platform and plans to add 30-35 centres across 10 cities, targeting 50,000 seats nationwide

'India pharma resilient despite disruptions; no blanket price hike planned'

India's pharma sector remains resilient despite West Asia disruptions, as the government advances biopharma, R&D and bulk drug manufacturing initiatives

Scheme to build bulk drugs' R&D, capacity in works, says Pharma secy

India plans a new support scheme for bulk drugs focused on R&D and capacity creation, while ruling out a broad medicine price hike despite rising input costs

Google leases 617,000 sq ft in Atrium Place, to pay ₹671 cr over 5 years

The lease includes a 15 per cent rent escalation every three years, the documents registered in April 2026 showed

Fertility rates in UP, Bihar, NE states drop closer to national average

Southern states largely see stable or marginally higher fertility levels, while northern and northeastern states record declines, indicating demographic convergence

CDSCO flags banned antibiotics in shrimp exports amid rising rejections

Regulator seeks state-wise enforcement data as EU, US and Japan reject consignments linked to over 40 farms

CDSCO directs drugmakers to maintain pharmacovigilance systems

The drug regulator has asked central and state authorities to verify compliance with pharmacovigilance requirements during routine inspections and regulatory reviews

Organised aesthetic clinics set to gain from tighter rules on Botox

CDSCO's move can lead to the formalisation of more than 35,000 skin clinics, stop the mushrooming of single-operator setups run by unqualified practitioners

Anant Raj to invest ₹20,000 crore in Haryana data centre expansion

Realty developer Anant Raj has signed an MoU with the Haryana government to invest Rs 20,000 crore in data centre infrastructure and create about 6,000 jobs

Bharti Realty eyes entry to commercial markets beyond Delhi-NCR

There's demand for the Worldmark brand in major markets across India: CEO Sayal

Airbnb leases 46,000 sq ft office space for GCC in DLF Cyber City

According to transaction documents accessed by Propstack, the lease commenced on October 1, 2025, at a rental rate of ₹132.5 per square foot per month

Worsening side effects of life in fast lane: Obesity, diabetes up sharply

Lifestyle diseases on the rise, shows NFHS-6, though insurance coverage, vaccination rates, maternal care, child health indicators have improved

MSME drugmakers face capital stress amid prolonged West Asia disruptions

Cost pressures, inventory strains likely to hit margins by 3-5%

Households' out-of-pocket expenditure on health care rose in FY23

Household spending drops from 64 percent over a decade amid rise in public health expenditure

DGCA issues Ebola SOP for airlines, mandates passenger screening

India's aviation regulator has directed airlines to collect self-declaration forms and monitor Ebola symptoms among passengers travelling from or transiting through Uganda and DRC

India office realty demand surge faces funding crunch: Knight Frank

Knight Frank says $2.3 billion dry capital with AIFs can meet only 14 per cent of India's annual office demand despite the country leading APAC occupier activity

AU Real Estate targets ₹1,600 crore sales from Ghaziabad housing project

The NCR-based developer plans to develop 831 residential units in Ghaziabad with an estimated investment of Rs 1,200 crore and completion targeted by 2031

Indian medical tourism grows in FY26 despite West Asia, B'desh shocks

Hospitals reported higher medical value tourism revenues in FY26 as complex procedures and market diversification helped offset lower patient inflows from key regions

Fortis Q4 net profit rises 44% on lower exceptional loss, higher revenue

Fortis Healthcare posted a 44% rise in Q4 profit, driven by strong hospital and diagnostics growth and lower exceptional losses